Can stem cell therapy cure all sport injuries?
No. Stem cell therapy cannot cure all sport injuries, and it is not a cure for common injuries such as knee, shoulder or back problems either.

Sports injuries include very different conditions, from muscle strains and tendon overuse to ligament ruptures, cartilage defects, fractures and disc problems, and each one has its own biology, natural course and best treatment. In research, mesenchymal stem cells (MSCs) have shown benefit in pain and function for some conditions, especially knee osteoarthritis, with growing evidence for tendon, ligament and spine problems. Many injuries heal well with rest and rehabilitation, and some, such as complete ligament or tendon ruptures, often require surgery. At Stem Cell Mexico, athlete protocols use only allogeneic MSCs from Wharton's jelly of the umbilical cord, applied locally with ultrasound guidance, as a complement to orthopedic care and physical therapy for selected injuries.
This guide explains which injuries are studied, where the evidence is stronger or weaker, and why careful diagnosis matters more than any single treatment.
Why "all sport injuries" is the wrong question
A sports injury is any damage to the body that happens during physical activity. The term covers:
- Acute injuries: sprains, strains, dislocations, fractures, ligament and tendon tears, meniscus tears and contusions.
- Overuse injuries: tendinopathies (such as tennis elbow, jumper's knee and Achilles tendinopathy), stress fractures, bursitis and plantar fasciitis.
- Degenerative conditions accelerated by sport: early osteoarthritis, cartilage wear and disc degeneration.
- Nerve and spinal injuries: nerve compression, herniated discs and, rarely, spinal cord injury.
- Head injuries: concussions, which require their own medical protocol.
These conditions involve different tissues with different blood supply and healing capacity. Muscle heals relatively well; tendons and ligaments heal slowly; cartilage has very limited ability to repair itself; bone heals well when properly aligned and stabilized. No single treatment, including stem cell therapy, can address all of them.
Where the evidence stands
Strongest evidence
Knee osteoarthritis. This is the most studied orthopedic use of MSCs. A 2024 systematic review and meta-analysis of randomized controlled trials in the Journal of Orthopaedic Translation found that MSC injections were associated with improvements in pain and function compared with controls in several trials. The authors also noted differences in cell sources, doses and study quality, and the need for larger, long-term trials. Evidence of true cartilage regrowth is limited.
Growing evidence
- Tendinopathies of the elbow, shoulder (rotator cuff), knee (patellar tendon) and Achilles tendon: small studies report improvements in some patients, but controlled trials are few.
- Partial ligament tears: cell therapy is explored to support healing, often alongside rehabilitation or surgery.
- Cartilage defects: cell-based approaches are investigated together with surgical techniques.
- Low back pain from disc degeneration: a 2026 meta-analysis of randomized trials of intradiscal MSCs suggests possible improvements in pain and function, with mixed results across studies.
Not supported or not appropriate as a stand-alone treatment
- Complete ruptures of the ACL, Achilles tendon or rotator cuff with retraction, which usually require surgical repair.
- Unstable or displaced fractures, which need alignment and fixation.
- Concussion and traumatic brain injury in the context of sport, which require a medical concussion protocol.
- Acute muscle strains, which usually heal with rest and progressive loading.
- Severe, bone-on-bone arthritis with major deformity, where joint replacement may be the most effective option.
What expert groups recommend
The 2020 NBA Orthobiologics Consensus Statement, written by physicians and researchers who care for professional athletes, concluded that interest in cell-based treatments is growing and that products vary widely. It recommended clear communication with athletes, careful documentation and participation in research.
Similarly, the International Olympic Committee (IOC) consensus paper on platelet-rich plasma (PRP) in sports medicine emphasized that biologic treatments should be evaluated with well-designed studies and that athletes should be informed about the limits of current evidence. These principles apply equally to stem cell therapies.
Stem cells, PRP and other biologic treatments
Patients often hear about several "regenerative" options at once. It helps to distinguish them:
- Platelet-rich plasma (PRP) is prepared from your own blood and concentrates platelets and growth factors. It contains no stem cells. It is studied for tendinopathies and knee osteoarthritis, with mixed results depending on the condition and preparation.
- MSCs from Wharton's jelly are living cells from donated umbilical cord tissue, studied for their anti-inflammatory and trophic signaling.
- Other biologics, such as exosomes or growth factor preparations, are at an earlier stage of research.
These options are sometimes combined, but combinations do not automatically make a treatment more effective, and each has its own evidence base.
How MSCs are thought to help
MSCs from Wharton's jelly do not become new tendon, ligament or cartilage in large amounts. Their proposed effect is paracrine: they release signals that may reduce inflammation, modulate the immune response and support the healing activity of local cells. This may translate into less pain and better function for some patients, which in turn can allow more effective rehabilitation. It does not mean that damaged structures are restored to their original condition.
Diagnosis comes first
Because each injury behaves differently, an accurate diagnosis is the most important step. This usually includes:
- A detailed history of how and when the injury happened.
- A physical examination by a sports medicine or orthopedic specialist.
- Imaging, such as MRI, ultrasound or X-rays, depending on the tissue involved.
- A review of previous treatments and rehabilitation.
With this information, the medical team can decide whether the injury is likely to heal with rehabilitation alone, whether it requires surgery, or whether a regenerative approach may be reasonable as part of the plan.
How treatment is done at Stem Cell Mexico
- Cells: allogeneic MSCs from Wharton's jelly of donated umbilical cords, obtained after healthy, full-term births with informed consent and donor screening. No autologous cells or other cell sources are used.
- Laboratory: produced in a COFEPRIS-licensed laboratory under Good Manufacturing Practice standards, with quality and safety testing before release.
- Application: local injection into the affected joint, tendon or ligament with ultrasound guidance, sometimes combined with an IV infusion when the medical team considers it appropriate.
- Rehabilitation: a structured return-to-activity plan, coordinated with your physical therapist.
- Follow-up: standardized measures of pain, function and range of motion at defined intervals.
A COFEPRIS license authorizes the facility and laboratory to operate.
Safety
Local MSC injections have a generally favorable safety profile in clinical research. The most common effects are temporary pain, swelling and stiffness at the injection site. Infection is rare but possible. No treatment is free of risk, and returning to full training too early can cause reinjury.
Anti-doping considerations
The World Anti-Doping Agency (WADA) Prohibited List includes a category for gene and cell doping (M3), which lists "the use of normal or genetically modified cells" among prohibited methods. If you are a drug-tested athlete, consult your team physician and your federation or anti-doping organization before treatment.
Warning signs when comparing clinics
Be cautious if a clinic:
- Claims to cure sports injuries or to treat "all" injuries the same way.
- Recommends treatment without reviewing imaging or examining the injury.
- Discourages surgery that a specialist has recommended for a complete rupture or unstable fracture.
- Says the treatment is risk-free or guarantees a return to sport.
Realistic expectations
- Results vary by injury and by patient.
- Improvement is usually gradual over weeks to months.
- Rehabilitation remains essential for returning to sport.
- Some injuries will still require surgery.
- Prevention matters: strength training, proper technique, adequate rest between sessions and gradual increases in training load reduce the risk of new or recurrent injuries, whatever treatment you receive.
What our patients usually receive
Based on the treatment plans our team prepares for patients, a typical protocol at Stem Cell Mexico includes:
- 20 to 40 million Wharton's jelly MSCs per treated area, applied by direct injection with ultrasound guidance, or fluoroscopy guidance for the spine.
- Platelet-rich plasma (PRP) in many plans, applied together with the cells.
- One night at our facilities with nursing and medical monitoring.
- Consultation with your doctor and the stem cell specialist, pre-treatment laboratory tests and ground transportation from the San Diego airport area.
- Your recent imaging: an MRI of the area no older than three months is requested; if yours is older, a new one can be scheduled in Tijuana on your arrival day.
Based on what patients tell us, many begin to notice improvement within a few days to a few weeks after the application, while others improve more gradually over the following months. Our team stays in contact after treatment to follow your progress and decide whether a second application or a PRP session could help.
Questions to ask during your evaluation
- What is my exact diagnosis, and what does the evidence say for this injury?
- Would my injury heal with rehabilitation alone, or does it need surgery?
- What results are realistic, and how will they be measured?
- How will treatment fit with my training and competition calendar?
- Are there anti-doping considerations for my sport?
Bottom line
Stem cell therapy cannot cure all sport injuries. Evidence is strongest for knee osteoarthritis and growing for tendon, ligament and spine problems, and cell therapy is not a stand-alone treatment for complete ruptures, unstable fractures or concussions. At Stem Cell Mexico, Wharton's jelly MSCs are offered as a complement to diagnosis-driven orthopedic care and rehabilitation for selected injuries. A medical evaluation can help determine whether this type of regenerative treatment is appropriate for your injury, goals and medical history.
References
- Cole BJ et al. The 2020 NBA Orthobiologics Consensus Statement. Orthopaedic Journal of Sports Medicine, 2021 (opens in a new tab)
- Tabet CG et al. Advanced therapy with mesenchymal stromal cells for knee osteoarthritis: systematic review and meta-analysis of randomized controlled trials. Journal of Orthopaedic Translation, 2024 (opens in a new tab)
- Engebretsen L et al. IOC consensus paper on the use of platelet-rich plasma in sports medicine. British Journal of Sports Medicine, 2010 (opens in a new tab)
- Rahyussalim et al. Intradiscal mesenchymal stem cell therapy for degenerative disc disease: a systematic review and meta-analysis of randomized trials. Asian Spine Journal, 2026 (opens in a new tab)
- World Anti-Doping Agency (WADA): The Prohibited List (opens in a new tab)
